- Home
- REGCP vs SVA Comparison
REGCP vs SVA Comparison
Compare REGCP & SVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REGCP
- SVA
- Stock Information
- Founded
- REGCP N/A
- SVA N/A
- Country
- REGCP United States
- SVA
- Employees
- REGCP 497
- SVA 3261
- Industry
- REGCP
- SVA
- Sector
- REGCP
- SVA
- Exchange
- REGCP Nasdaq
- SVA NYSE
- Market Cap
- REGCP N/A
- SVA N/A
- IPO Year
- REGCP N/A
- SVA N/A
- Fundamental
- Price
- REGCP $23.50
- SVA N/A
- Analyst Decision
- REGCP
- SVA
- Analyst Count
- REGCP 0
- SVA 0
- Target Price
- REGCP N/A
- SVA N/A
- AVG Volume (30 Days)
- REGCP N/A
- SVA N/A
- Earning Date
- REGCP N/A
- SVA N/A
- Dividend Yield
- REGCP N/A
- SVA N/A
- EPS Growth
- REGCP N/A
- SVA N/A
- EPS
- REGCP N/A
- SVA N/A
- Revenue
- REGCP N/A
- SVA N/A
- Revenue This Year
- REGCP N/A
- SVA N/A
- Revenue Next Year
- REGCP N/A
- SVA N/A
- P/E Ratio
- REGCP N/A
- SVA N/A
- Revenue Growth
- REGCP N/A
- SVA N/A
- 52 Week Low
- REGCP N/A
- SVA N/A
- 52 Week High
- REGCP N/A
- SVA N/A
- Technical
- Relative Strength Index (RSI)
- REGCP 32.39
- SVA N/A
- Support Level
- REGCP $23.19
- SVA N/A
- Resistance Level
- REGCP $24.39
- SVA N/A
- Average True Range (ATR)
- REGCP 0.25
- SVA 0.00
- MACD
- REGCP -0.08
- SVA 0.00
- Stochastic Oscillator
- REGCP 20.10
- SVA 0.00
About REGCP Regency Centers Corporation
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.